fda_approval · anda · info
MACLEODS PHARMS LTD — ANDA approval: RIFAPENTINE (unspecified)
- Event date
- 2026-06-23 00:00:00Z
- Observed
- 2026-07-09 22:53:23Z
- Source ID
- ANDA217042-1
- Payload hash
- 9abe684f0d47c7ce84bc72d1…
Summary
MACLEODS PHARMS LTD received ANDA approval for RIFAPENTINE (unspecified) on 2026-06-23. Dosage form: TABLET. Application #: ANDA217042.
Entities
Informational only. Not legal, financial, or medical advice.